Corcept Therapeutics Inc.

CORT ·Healthcare, Drug Manufacturers - General, United States

Net Cash Flow Breakdown

FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015

Total Cash from Operations: $164.2M